A. Abeliovich, Y. Schmitz, I. Farinas, D. Choi-lundberg, W. H. Ho et al., Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system, Neuron, vol.25, pp.80886-80893, 2000.

K. J. Ahn, S. R. Paik, K. C. Chung, K. , and J. , Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein, 2006.

, J. Neurochem, vol.97, pp.265-279

I. Alafuzoff, P. G. Ince, T. Arzberger, S. Al-sarraj, J. Bell et al., Staging/typing of lewy body related alpha-synuclein pathology: a study of the brainnet Europe consortium, Acta Neuropathol, vol.117, pp.635-652, 2009.

L. Alvarez-erviti, Y. Couch, J. Richardson, J. M. Cooper, and M. J. Wood, Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line, Neurosci. Res, vol.69, pp.337-342, 2011.

L. Alvarez-erviti, Y. Seow, A. H. Schapira, C. Gardiner, I. L. Sargent et al., Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission, Neurobiol. Dis, vol.42, pp.360-367, 2011.

S. Appel-cresswell, C. Vilarino-guell, M. Encarnacion, H. Sherman, I. Yu et al., Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease, Mov. Disord, vol.28, pp.811-813, 2013.

A. Athanassiadou, G. Voutsinas, L. Psiouri, E. Leroy, M. H. Polymeropoulos et al., Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein, Am. J. Hum. Genet, vol.65, pp.555-558, 1999.

P. K. Auluck, G. Caraveo, and S. Lindquist, Alpha-synuclein: membrane interactions and toxicity in Parkinson's disease, Annu. Rev. Cell Dev. Biol, vol.26, pp.211-233, 2010.

M. Beekes, A. Thomzig, W. J. Schulz-schaeffer, and R. Burger, Is there a risk of prion-like disease transmission by Alzheimer-or Parkinson-associated protein particles?, Acta Neuropathol, vol.128, pp.463-476, 2014.

A. Bloch, A. Probst, H. Bissig, H. Adams, and M. Tolnay, Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects, Neuropathol. Appl. Neurobiol, vol.32, pp.284-295, 2006.

R. Borghi, R. Marchese, A. Negro, L. Marinelli, G. Forloni et al., Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects, Neurosci. Lett, vol.287, pp.65-67, 2000.

L. Bousset, L. Pieri, G. Ruiz-arlandis, J. Gath, P. H. Jensen et al., Structural and functional characterization of two alpha-synuclein strains, Nat. Commun, vol.4, p.2575, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01183047

H. Braak, K. Del-tredici, U. Rub, R. A. De-vos, E. N. Jansen-steur et al., Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol. Aging, vol.24, pp.197-211, 2003.

P. Brundin, J. Y. Li, J. L. Holton, O. Lindvall, and T. Revesz, Research in motion: the enigma of Parkinson's disease pathology spread, Nat. Rev. Neurosci, vol.9, pp.741-745, 2008.

R. E. Burke, W. T. Dauer, and J. P. Vonsattel, A critical evaluation of the braak staging scheme for Parkinson's disease, Ann. Neurol, vol.64, pp.485-491, 2008.

J. Burre, M. Sharma, and T. C. Sudhof, Alpha-synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation, Proc. Natl. Acad. Sci. U.S.A, vol.111, pp.4274-4283, 2014.

D. E. Cabin, K. Shimazu, D. Murphy, N. B. Cole, W. Gottschalk et al., Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein, J. Neurosci, vol.22, pp.8797-8807, 2002.

S. Chandra, G. Gallardo, R. Fernandez-chacon, O. M. Schluter, and T. C. Sudhof, Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration, Cell, vol.123, pp.383-396, 2005.

R. H. Chen, S. Wislet-gendebien, F. Samuel, N. P. Visanji, G. Zhang et al., Alpha-synuclein membrane association is regulated by the Rab3a Frontiers in Neuroanatomy www.frontiersin.org recycling machinery and presynaptic activity, J. Biol. Chem, vol.288, pp.7438-7449, 2013.

S. J. Chinta, J. K. Mallajosyula, A. Rane, and J. K. Andersen, Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo, Neurosci. Lett, vol.486, pp.235-239, 2010.

J. M. Choi, M. S. Woo, H. I. Ma, S. Y. Kang, Y. H. Sung et al., Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease, Neurogenetics, vol.9, pp.263-269, 2008.

F. Cicchetti, S. Lacroix, G. Cisbani, N. Vallieres, M. Saint-pierre et al., Mutant huntingtin is present in neuronal grafts in Huntington disease patients, Ann. Neurol, vol.76, pp.31-42, 2014.

A. A. Cooper, A. D. Gitler, A. Cashikar, C. M. Haynes, K. J. Hill et al., Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models, Science, vol.313, pp.324-328, 2006.

K. M. Danzer, D. Haasen, A. R. Karow, S. Moussaud, M. Habeck et al., Different species of alpha-synuclein oligomers induce calcium influx and seeding, J. Neurosci, vol.27, pp.9220-9232, 2007.

K. M. Danzer, S. K. Krebs, M. Wolff, G. Birk, and B. Hengerer, Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology, J. Neurochem, vol.111, pp.192-203, 2009.

K. M. Danzer, W. P. Ruf, P. Putcha, D. Joyner, T. Hashimoto et al., Heat-shock protein 70 modulates toxic extracellular alpha-synuclein oligomers and rescues trans-synaptic toxicity, FASEB J, vol.25, pp.326-336, 2011.

P. Desplats, H. J. Lee, E. J. Bae, C. Patrick, E. Rockenstein et al., Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.13010-13015, 2009.

L. Devi, V. Raghavendran, B. M. Prabhu, N. G. Avadhani, and H. K. Anandatheerthavarada, Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain, J. Biol. Chem, vol.283, pp.9089-9100, 2008.

D. C. Dewitt and E. Rhoades, Alpha-synuclein can inhibit SNAREmediated vesicle fusion through direct interactions with lipid bilayers, Biochemistry, vol.52, pp.2385-2387, 2013.

D. W. Dickson, Parkinson's disease and parkinsonism: neuropathology. Cold Spring Harb, Perspect. Med, vol.2, p.9258, 2012.

D. W. Dickson, H. Uchikado, H. Fujishiro, and Y. Tsuboi, Evidence in favor of Braak staging of Parkinson's disease, Mov. Disord, vol.25, pp.78-82, 2010.

O. M. El-agnaf, S. A. Salem, K. E. Paleologou, L. J. Cooper, N. J. Fullwood et al., Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma, FASEB J, vol.17, pp.1945-1947, 2003.

E. Emmanouilidou, K. Melachroinou, T. Roumeliotis, S. D. Garbis, M. Ntzouni et al., Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival, J. Neurosci, vol.30, pp.6838-6851, 2010.

E. Gelpi, J. Navarro-otano, E. Tolosa, C. Gaig, Y. Compta et al., Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders, Mov. Disord, vol.29, pp.1010-1018, 2014.

A. D. Gitler, B. J. Bevis, J. Shorter, K. E. Strathearn, S. Hamamichi et al., The Parkinson's disease protein alpha-synuclein disrupts cellular rab homeostasis, Proc. Natl. Acad. Sci. U.S.A, vol.105, pp.145-150, 2008.

K. Gousset, E. Schiff, C. Langevin, Z. Marijanovic, A. Caputo et al., Prions hijack tunnelling nanotubes for intercellular spread, Nat. Cell Biol, vol.11, pp.328-336, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-00368712

C. Guardia-laguarta, E. Area-gomez, C. Rub, Y. Liu, J. Magrane et al., Alpha-synuclein is localized to mitochondria-associated ER membranes, J. Neurosci, vol.34, pp.249-259, 2014.

J. L. Guo, D. J. Covell, J. P. Daniels, M. Iba, A. Stieber et al., Distinct alpha-synuclein strains differentially promote tau inclusions in neurons, Cell, vol.154, pp.103-117, 2013.

J. L. Guo and V. M. Lee, Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases, Nat. Med, vol.20, pp.130-138, 2014.

G. Halliday, H. Mccann, and C. Shepherd, Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?, Expert Rev. Neurother, vol.12, pp.673-686, 2012.

C. Hansen, E. Angot, A. L. Bergstrom, J. A. Steiner, L. Pieri et al., Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells, J. Clin. Invest, vol.121, pp.715-725, 2011.

S. Holmqvist, O. Chutna, L. Bousset, P. Aldrin-kirk, W. Li et al., Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats, Acta Neuropathol, vol.128, pp.805-820, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01155404

D. J. Irwin, J. Y. Abrams, L. B. Schonberger, E. W. Leschek, J. L. Mills et al., Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone, JAMA Neurol, vol.70, pp.462-468, 2013.

J. M. Jenco, A. Rawlingson, B. Daniels, and A. J. Morris, Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha-and beta-synucleins, Biochemistry, vol.37, pp.4901-4909, 1998.

F. Kamp, N. Exner, A. K. Lutz, N. Wender, J. Hegermann et al., Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1, EMBO J, vol.29, pp.3571-3589, 2010.

C. S. Ki, E. F. Stavrou, N. Davanos, W. Y. Lee, E. J. Chung et al., The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease, Clin. Genet, vol.71, pp.471-473, 2007.

J. H. Kordower, Y. Chu, R. A. Hauser, T. B. Freeman, and C. W. Olanow, Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease, Nat. Med, vol.14, pp.504-506, 2008.

J. H. Kordower, H. B. Dodiya, A. M. Kordower, B. Terpstra, K. Paumier et al., Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat, Neurobiol. Dis, vol.43, pp.552-557, 2011.

R. Kruger, W. Kuhn, T. Muller, D. Woitalla, M. Graeber et al., Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease, Nat. Genet, vol.18, pp.106-108, 1998.

K. E. Larsen, Y. Schmitz, M. D. Troyer, E. Mosharov, P. Dietrich et al., Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis, J. Neurosci, vol.26, pp.11915-11922, 2006.

H. J. Lee, S. Patel, and S. J. Lee, Intravesicular localization and exocytosis of alpha-synuclein and its aggregates, J. Neurosci, vol.25, pp.6016-6024, 2005.

H. J. Lee, J. E. Suk, E. J. Bae, J. H. Lee, S. R. Paik et al., Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein, 2008.

, Int. J. Biochem. Cell Biol, vol.40, pp.1835-1849

H. J. Lee, J. E. Suk, E. J. Bae, and S. J. Lee, Clearance and deposition of extracellular alpha-synuclein aggregates in microglia, Biochem. Biophys. Res. Commun, vol.372, pp.423-428, 2008.

H. J. Lee, J. E. Suk, C. Patrick, E. J. Bae, J. H. Cho et al., Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies, J. Biol. Chem, vol.285, pp.9262-9272, 2010.

S. Lesage, M. Anheim, F. Letournel, L. Bousset, A. Honore et al., G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome, Ann. Neurol, vol.73, pp.459-471, 2013.

J. Y. Li, E. Englund, J. L. Holton, D. Soulet, P. Hagell et al., Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest hostto-graft disease propagation, Nat. Med, vol.14, pp.501-503, 2008.

G. Liu, C. Zhang, J. Yin, X. Li, F. Cheng et al., Alpha-synuclein is differentially expressed in mitochondria from different rat brain regions and dosedependently down-regulates complex I activity, Neurosci. Lett, vol.454, pp.187-192, 2009.

V. Loeb, E. Yakunin, A. Saada, S. , and R. , The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition, J. Biol. Chem, vol.285, pp.7334-7343, 2010.

, Frontiers in Neuroanatomy www.frontiersin.org

K. C. Luk, V. Kehm, J. Carroll, B. Zhang, P. O'brien et al., Pathological alpha-synuclein transmission initiates Parkinsonlike neurodegeneration in nontransgenic mice, Science, vol.338, pp.949-953, 2012.

K. C. Luk, V. M. Kehm, B. Zhang, P. O'brien, J. Q. Trojanowski et al., Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice, J. Exp. Med, vol.209, pp.975-986, 2012.

K. C. Luk, C. Song, P. O'brien, A. Stieber, J. R. Branch et al., Exogenous alpha-synuclein fibrils seed the formation of lewy body-like intracellular inclusions in cultured cells, Proc. Natl. Acad. Sci. U.S.A, vol.106, 2009.

L. Maroteaux, J. T. Campanelli, and R. H. Scheller, Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal, J. Neurosci, vol.8, pp.2804-2815, 1988.

L. J. Martin, Y. Pan, A. C. Price, W. Sterling, N. G. Copeland et al., Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death, J. Neurosci, vol.26, pp.41-50, 2006.

M. Martinez-vicente and M. Vila, Alpha-synuclein and protein degradation pathways in Parkinson's disease: a pathological feed-back loop, Exp. Neurol, vol.247, pp.308-313, 2013.

M. Masuda-suzukake, T. Nonaka, M. Hosokawa, M. Kubo, A. Shimozawa et al., Pathological alpha-synuclein propagates through neural networks, Acta Neuropathol. Commun, vol.2, p.88, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01073069

M. Masuda-suzukake, T. Nonaka, M. Hosokawa, T. Oikawa, T. Arai et al., Prion-like spreading of pathological alpha-synuclein in brain, Brain, vol.136, pp.1128-1138, 2013.

I. Mendez, A. Vinuela, A. Astradsson, K. Mukhida, P. Hallett et al., Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years, Nat. Med, vol.14, pp.507-509, 2008.

A. L. Mougenot, S. Nicot, A. Bencsik, E. Morignat, J. Verchere et al., Prion-like acceleration of a synucleinopathy in a transgenic mouse model, Neurobiol. Aging, vol.33, pp.2225-2228, 2012.

D. D. Murphy, S. M. Rueter, J. Q. Trojanowski, and V. M. Lee, Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons, J. Neurosci, vol.20, pp.3214-3220, 2000.

K. Nakamura, V. M. Nemani, F. Azarbal, G. Skibinski, J. M. Levy et al., Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein, J. Biol. Chem, vol.286, pp.20710-20726, 2011.

J. Navarro-otano, E. Gelpi, C. A. Mestres, E. Quintana, S. Rauek et al., Alpha-synuclein aggregates in epicardial fat tissue in living subjects without parkinsonism, Parkinsonism Relat. Disord, vol.19, pp.27-31, 2013.

T. Nonaka, S. T. Watanabe, T. Iwatsubo, and M. Hasegawa, Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases, J. Biol. Chem, vol.285, pp.34885-34898, 2010.

F. Pan-montojo, O. Anichtchik, Y. Dening, L. Knels, S. Pursche et al., Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice, PLoS ONE, vol.5, p.8762, 2010.

F. Pan-montojo, M. Schwarz, C. Winkler, M. Arnhold, G. A. O'sullivan et al., Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice, Sci. Rep, vol.2, p.898, 2012.

M. H. Polymeropoulos, C. Lavedan, E. Leroy, S. E. Ide, A. Dehejia et al., Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, vol.276, pp.2045-2047, 1997.

A. Puschmann, O. A. Ross, C. Vilarino-guell, S. J. Lincoln, J. M. Kachergus et al., A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction, Parkinsonism Relat. Disord, vol.15, pp.627-632, 2009.

A. Recasens, B. Dehay, J. Bove, I. Carballo-carbajal, S. Dovero et al., Lewy body extracts from Parkinson disease brains trigger alphasynuclein pathology and neurodegeneration in mice and monkeys, Ann. Neurol, vol.75, pp.351-362, 2014.

N. L. Rey, G. H. Petit, L. Bousset, R. Melki, and P. Brundin, Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice, Acta Neuropathol, vol.126, pp.555-573, 2013.

J. F. Reyes, N. L. Rey, L. Bousset, R. Melki, P. Brundin et al., , 2014.

, Alpha-synuclein transfers from neurons to oligodendrocytes, Glia, vol.62, pp.387-398

A. D. Reynolds, J. G. Glanzer, I. Kadiu, M. Ricardo-dukelow, A. Chaudhuri et al., Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease, J. Neurochem, vol.104, pp.1504-1525, 2008.

A. N. Sacino, M. Brooks, A. B. Mckinney, M. A. Thomas, G. Shaw et al., Brain Injection of alpha-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker, J. Neurosci, vol.34, pp.12368-12378, 2014.

A. N. Sacino, M. Brooks, M. A. Thomas, A. B. Mckinney, S. Lee et al., Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice, Proc. Natl. Acad. Sci. U.S.A, vol.111, pp.10732-10737, 2014.

A. N. Sacino, M. Brooks, M. A. Thomas, A. B. Mckinney, N. H. Mcgarvey et al., Amyloidogenic alpha-synuclein seeds do not invariably induce rapid, widespread pathology in mice, Acta Neuropathol, vol.127, pp.645-665, 2014.

H. Sato, T. Kato, A. , and S. , Potential of cellular and animal models based on a prion-like propagation of alpha-synuclein for assessing antiparkinson agents, Mol. Neurobiol, 2014.

P. J. Spira, D. M. Sharpe, G. Halliday, J. Cavanagh, and G. A. Nicholson, Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation, Ann. Neurol, vol.49, pp.313-319, 2001.

J. Y. Sung, J. Kim, S. R. Paik, J. H. Park, Y. S. Ahn et al., Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein, 2001.

, J. Biol. Chem, vol.276, pp.27441-27448

J. Y. Sung, S. M. Park, C. H. Lee, J. W. Um, H. J. Lee et al., Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases, J. Biol. Chem, vol.280, pp.25216-25224, 2005.

N. Thayanidhi, J. R. Helm, D. C. Nycz, M. Bentley, Y. Liang et al., Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs, Mol. Biol. Cell, vol.21, pp.1850-1863, 2010.

H. T. Tran, C. H. Chung, M. Iba, B. Zhang, J. Q. Trojanowski et al., Alpha-synuclein immunotherapy blocks uptake and templated propagation of misfolded alpha-synuclein and neurodegeneration, Cell Rep, vol.7, pp.2054-2065, 2014.

A. Ulusoy, R. Rusconi, B. I. Perez-revuelta, R. E. Musgrove, M. Helwig et al., Caudo-rostral brain spreading of alphasynuclein through vagal connections, EMBO Mol. Med, vol.5, pp.1051-1059, 2013.

L. A. Volpicelli-daley, K. C. Luk, T. P. Patel, S. A. Tanik, D. M. Riddle et al., Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death, Neuron, vol.72, pp.57-71, 2011.

L. Wang, U. Das, D. A. Scott, Y. Tang, P. J. Mclean et al., Alphasynuclein multimers cluster synaptic vesicles and attenuate recycling, Curr. biol, vol.24, pp.2319-2326, 2014.

J. C. Watts, K. Giles, A. Oehler, L. Middleton, D. T. Dexter et al., Transmission of multiple system atrophy prions to transgenic mice, Proc. Natl. Acad. Sci. U.S.A, vol.110, pp.19555-19560, 2013.

E. A. Waxman and B. I. Giasson, A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that Frontiers in Neuroanatomy www.frontiersin.org inhibit amyloid formation, J. Neurochem, vol.113, pp.374-388, 2010.

J. J. Zarranz, J. Alegre, J. C. Gomez-esteban, E. Lezcano, R. Ros et al., The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia, Ann. Neurol, vol.55, pp.164-173, 2004.

W. Zhang, T. Wang, Z. Pei, D. S. Miller, X. Wu et al., Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease, FASEB J, vol.19, pp.533-542, 2005.